France· FR:62516116
OFEV 25 mg, capsule molle
A medicinal product containing ésilate de nintédanib, registered in France by BOEHRINGER INGELHEIM INTERNATIONAL, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉSILATE DE NINTÉDANIB
- Manufacturer
- BOEHRINGER INGELHEIM INTERNATIONAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009303089361 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s)EUR 1.31
- cip1334009303089431 flacon(s) polyéthylène haute densité (PEHD) de 180 capsule(s)EUR 1.31
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ésilate de nintédanib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainOFEV 25 MG CAPSULAS BLANDASBoehringer Ingelheim International Gmbh
- IcelandOfevBoehringer Ingelheim International GmbH*
- NorwayOfevBoehringer Ingelheim International GmbH
- PolandOfevBoehringer Ingelheim International GmbH
- SwedenOfev 25 mg Kapsel, mjukBoehringer Ingelheim International GmbH
- NetherlandsGevesla 100 mg, zachte capsulesSandoz B.V.
- GermanyNintedanibEugia Pharma (Malta) Limited
- United KingdomNintedanib 100mg capsulesTeva UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Nintedanib Cipla, Nintedanib Ratiopharm
- Belgium · Nintedanib Accordpharma, Nintedanib Eg
- Cyprus · Nintedanib Teva
- Czechia · Nintedanib Glenmark, Nintedanib Sandoz
- Germany · Nintedanib, Nintedanib 1 A Pharma
- Denmark · Nintedanib "sandoz", Nintedanib Glenmark
- Estonia · Agarf, Nintedanib Sandoz
- Spain · Nintedanib, Nintedanib Accordpharma
- Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
- United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
- Greece · Nifib, Nindraf
- Croatia · Gevesla, Nintedanib Accordpharma
- Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
- Ireland · Nintedanib Accordpharma, Nintedanib Clonmel
- Iceland · Agarf, Nintedanib Accord
- Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
- Liechtenstein · Nintedanib Accord, Nintedanib Viatris
- Lithuania · Agarf, Nintedanib Sandoz
- Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
- Latvia · Agarf, Nintedanib Sandoz
- Malta · Nifiden Adalvo, Nintedanib Adalvo
- Netherlands · Gevesla, Nintedanair
- Norway · Nintedanib Accord, Nintedanib Devatis
- Poland · Nintedanib, Nintedanib Accordpharma
- Portugal · Nintedanib Accordpharma, Nintedanib Eugia
- Romania · Gevesla, Nintedanib Dr. Reddy’s
- Sweden · Nintedanib Devatis, Nintedanib Glenmark
- Slovenia · Nintedanib Accordpharma, Nintedanib Stada
- Slovakia · Nintedanib Stada, Nintedanib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c42fe327-c62f-4349-98e0-975cefe9acdb GET /v1/drugs/c42fe327-c62f-4349-98e0-975cefe9acdb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62516116",
"date_amm": "2025-02-12",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/979",
"substance": "ÉSILATE DE NINTÉDANIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "capsule molle",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ésilate de nintédanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.